|
|
|
| With a strong focus on quality and patient-centricity, GC Cell provides seamless solutions from process development to clinical material and commercial production. We have a proven track record and are involved in cutting-edge research and development projects. GC Cell fully understands the unique challenges around Cell & Gene Therapy development and manufacturing. Explore our end-to-end, customer-centric CDMO services that are helping to bring more breakthrough treatments to patients. Learn more |
|
|
|
|
|
|
|
|
| The Importance Of Scalability In Viral Vectors | Article | MilliporeSigma | Diseases that lack a cure, or even treatment, may be addressed with new gene therapeutic classes. This potential has spurred new investments in the drug development and commercialization space. |
|
|
|
|
| Cell Culture Solutions To Unlock Your Cell Performance | Infographic | Nucleus Biologics | Researchers say turnaround time for custom reagents and media is a large bottleneck for the manufacturing of emerging therapies. Get your therapy to market faster with custom solutions. |
|
|
|
| Automated Evidence Of Clonality | Application Note | Advanced Instruments, Inc. | Proof of monoclonality is regularly a bottleneck in the cell line development workflow. Discover an innovative piece of cell line development imaging technology. |
|
|
|
| Evaluating Cell Culture Medium Performance In CAR T Processes | Application Note | By Benedikt Steinle, Evelien Nijssen, Sarah Carqueville, Ursula Schultz, and Charlotte Tardivet, Sartorius | This study examines the expansion, functionality, and phenotype of CAR T-cells cultured in the CellGenix GMP T cell culture medium (TCM) compared to other commercially available T cell media. |
|
|
|
|
By Tyler Menichiello, contributing editor | Dr. Michael Hufford, CEO of LyGenesis, believes in leveraging natural biology to develop cell therapies. Learn how the company’s doing so to grow ectopic livers inside patients with end-stage liver disease. |
|
|
|
|
|
| With additional cell therapy approvals on the horizon, a diverse array of products and platforms are needed to ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall COGS. Join Cell & Gene Live for a digital discussion on the next generation of platforms and innovative technologies. Registration is free thanks to the support of Invetech. |
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|